141 related articles for article (PubMed ID: 30585766)
1. Clinical Value of Positron Emission Tomography-Computed Tomography Combined with Ultrasound in Detection of Primary Tumors in Patients with Malignant Ascites.
Liu J; Liu G; Liu X; Zhu X; Wang Y; Gou B; You L
Cancer Biother Radiopharm; 2019 Apr; 34(3):203-207. PubMed ID: 30585766
[TBL] [Abstract][Full Text] [Related]
2. Value of
Han N; Sun X; Qin C; Hassan Bakari K; Wu Z; Zhang Y; Lan X
AJR Am J Roentgenol; 2018 May; 210(5):1155-1163. PubMed ID: 29629798
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings.
Kunawudhi A; Wong AK; Alkasab TK; Mahmood U
Asian Pac J Cancer Prev; 2016; 17(8):4143-7. PubMed ID: 27644675
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
Tsatalpas P; Beuthien-Baumann B; Kropp J; Manseck A; Tiepolt C; Hakenberg OW; Burchert W; Franke WG; Wirth MP
Urol Int; 2002; 68(3):157-63. PubMed ID: 11919460
[TBL] [Abstract][Full Text] [Related]
7. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
8. Limited Identification of Dual-time-point Positron Emission Tomography/Computed Tomography in Advanced Colorectal Neoplasms.
Kashiwagi K; Nakazato Y; Arai M; Iwasaki E; Naganuma M; Inoue N; Iwao Y; Ogata H; Murakami K; Kanai T
Intern Med; 2017; 56(11):1287-1292. PubMed ID: 28566588
[TBL] [Abstract][Full Text] [Related]
9. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
10. Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.
Naganawa S; Yoshikawa T; Yasaka K; Maeda E; Hayashi N; Abe O
Medicine (Baltimore); 2017 Nov; 96(46):e8832. PubMed ID: 29145346
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer.
Zhang S; Li W; Liang F
Oncotarget; 2016 Jul; 7(30):48600-48606. PubMed ID: 27203206
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of
Lauridsen TK; Iversen KK; Ihlemann N; Hasbak P; Loft A; Berthelsen AK; Dahl A; Dejanovic D; Albrecht-Beste E; Mortensen J; Kjær A; Bundgaard H; Bruun NE
Int J Cardiovasc Imaging; 2017 May; 33(5):751-760. PubMed ID: 28050751
[TBL] [Abstract][Full Text] [Related]
13. Ascites metabolism measurement enhanced the diagnostic value and accuracy of prognostic evaluation in 18F-FDG PET/CT studies in malignant ascites patients.
Li XJ; Li FQ; Han JK; Zhao ZH; Song ZG; Dai XZ
Nucl Med Commun; 2013 Jun; 34(6):544-50. PubMed ID: 23511926
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
18. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Kim ES; Yoon DY; Moon JY; Baek S; Han YM; Seo YL; Yun EJ
Acta Radiol; 2019 Feb; 60(2):186-195. PubMed ID: 29754496
[TBL] [Abstract][Full Text] [Related]
19. A study of the pathological outcome of positron emission tomography-computed tomography 2-(
Gupta G; Gandhi JS; Sharma A; Pasricha S; Mehta A; Rao A; Kamboj M
J Cancer Res Ther; 2017; 13(6):1000-1006. PubMed ID: 29237966
[TBL] [Abstract][Full Text] [Related]
20. Clinical Values of Combined Diffused Optical Tomography and PET-CT in the Diagnosis of Breast Cancer.
Wang HY; Jin XN; Jiang YX; Zhu ZH; Xu Y; Zhu QL; Dai Q; Li JC; Li F; Sun Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):682-687. PubMed ID: 29125112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]